SBSamuel S. Bruce

Samuel S. Bruce

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Samuel S. Bruce has a total of 59 co-authors. Here are the top co-authors by number of shared publications:

  • Babak Benjamin Navi

    Weill Cornell Medicine

    5 shared publications
  • Hooman Kamel

    Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology Weill Cornell Medicine New York NY

    5 shared publications
  • Neal S. Parikh

    Department of Neurology, Weill Cornell Medicine, New York, New York

    3 shared publications
  • Santosh B. Murthy

    Department of Neurology and Feil Family Brain and Mind Research Institute, Weill Cornell Medicine Clinical and Translational Neuroscience Unit New York NY USA

    3 shared publications
  • Alexander E. Merkler

    Clinical and Translational Neuroscience Unit, Department of Neurology and Feil Family Brain and Mind Research Institute, Weill Cornell Medicine New York New York USA

    2 shared publications
  • Alexander E. Merkler

    Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, NY

    2 shared publications

Latest Publications

  • Prevalence of Cerebral Amyloid Angiopathy and Associated Risk of Subsequent Ischemic and Hemorrhagic Stroke and Mortality in a Nationwide Cohort

    by Samuel S. Bruce, Cenai Zhang, Ava L. Liberman, Alexander E. Merkler, Babak B. Navi, Gloria C. Chiang, Costantino Iadecola, Hooman Kamel, Santosh B. Murthy

    Objective: There are limited population‐based data regarding the prevalence of cerebral amyloid angiopathy (CAA) and associated risks of mortality and incident cerebrovascular events.Methods: We performed a retrospective cohort study using inpatient and outpatient claims from 2008 to 2022 from a 5% national sample of Medicare beneficiaries. CAA and ischemic and hemorrhagic stroke were identified using validated International Classification of Diseases 10th Revision (ICD‐10) codes. We ascertained CAA from October 1, 2015 through 2022, and used data from 2008 through September 30, 2015 to ascertain comorbidities including prevalent stroke. We used Cox regression to examine the association of CAA with subsequent death and incident stroke subtypes after adjustment for demographics, vascular risk factors, and Charlson comorbidities.Results: Among 1,920,312 Medicare beneficiaries in our sample, 2,161 (11.3 per 10,000) had a diagnosis of CAA. In adjusted Cox regression analysis, there was an association between CAA and subsequent mortality (HR 4.9; 95% CI 4.6–5.2). Among 1,872,474 patients without prevalent stroke, including 900 of the CAA patients, there was a significant association between CAA and an increased risk of any stroke (HR 8.0; 95% CI 6.7–9.6), ischemic stroke (HR 4.6; 95% CI 3.6–6.0), intracerebral hemorrhage (HR 26.9; 95% CI 20.3–35.6), and subarachnoid hemorrhage (HR 21.6; 95% CI 12.2–38.1). After a diagnosis of CAA, absolute risks of ischemic stroke and intracerebral hemorrhage were broadly similar.Interpretation: In a large, nationwide cohort of Medicare beneficiaries, the prevalence of clinically diagnosed CAA was approximately 11 per 10,000. CAA was associated with an increased risk of mortality and incident stroke, both hemorrhagic and ischemic. ANN NEUROL 2025;98:249–257


  • Nontraumatic Intracranial Hemorrhage and Risk of Incident Dementia in US Medicare Beneficiaries

    by Samuel S. Bruce, Anokhi Pawar, Vanessa Liao, Alexander E. Merkler, Ava L. Liberman, Babak B. Navi, Costantino Iadecola, Hooman Kamel, Cenai Zhang, Santosh B. Murthy

    BACKGROUND: To study the risk of incident dementia after a nontraumatic intracranial hemorrhage in a diverse US population and evaluate whether this risk is different for the subtypes of intracranial hemorrhage. METHODS: We performed a retrospective cohort study using both inpatient and outpatient claims data on a 5% sample of Medicare beneficiaries per year between January 1, 2008 and December 31, 2018. The exposure was a new diagnosis of nontraumatic intracranial hemorrhage, defined as a composite of intracerebral hemorrhage, subarachnoid hemorrhage, and subdural hemorrhage. The outcome was a first-ever diagnosis of dementia. The exposure and outcomes were identified using validated International Classification of Diseases, Ninth and Tenth Revisions, Clinical Modification diagnosis codes. We excluded patients who had prevalent intracranial hemorrhage or dementia to ensure that only incident cases were counted in our analyses. In the primary analysis, we used Cox regression to study the risk of dementia after intracranial hemorrhage, after adjusting for demographics and comorbidities. In secondary analyses, the risks of dementia in different subtypes of intracranial hemorrhage were studied. RESULTS: Among 2.1 million patients, 14 775 had a diagnosis of intracranial hemorrhage with an incidence rate of 1.2 (95% CI, 1.1–1.2) per 1000 person-years. Incident dementia was diagnosed in 2527 (17.1%) of the 14 775 patients with intracranial hemorrhage and in 260 691 (12.8%) of the 2 033 190 patients without intracranial hemorrhage. During a median follow-up of 5.6 (interquartile range, 3.0–9.0) years, the incidence rate of dementia was 8.6 (95% CI, 8.1–8.9) per 100 person-years among patients with intracranial hemorrhage and 2.2 (95% CI, 2.0–2.4) per 100 person-years among patients without intracranial hemorrhage. In an adjusted Cox regression analysis, intracranial hemorrhage was associated with an increased risk of incident dementia (hazard ratio, 2.0 [95% CI, 1.9–2.2]). In secondary analyses, a higher risk of incident dementia was observed with intracerebral hemorrhage (hazard ratio, 2.4 [95% CI, 2.2–2.5]), subarachnoid hemorrhage (hazard ratio, 1.99 [95% CI, 1.7–2.2]), and subdural hemorrhage (hazard ratio, 1.6 [95% CI, 1.4–1.7]). CONCLUSIONS: In a large, heterogeneous cohort of elderly US participants, we found that intracranial hemorrhage was independently associated with a 2-fold increased risk of incident dementia. This elevated risk was consistently observed across subtypes of intracranial hemorrhage.


  • Risk of Major Adverse Cardiovascular Events After Emergency Department Visits for Hypertensive Urgency

    by Ava L. Liberman, Junaid Razzak, Richard I. Lappin, Babak B. Navi, Samuel S. Bruce, Vanessa Liao, Jed H. Kaiser, Catherine Ng, Alan Z. Segal, Hooman Kamel

    BACKGROUND: Chronic hypertension is an established long-term risk factor for major adverse cardiovascular events (MACEs). However, little is known about short-term MACE risk after hypertensive urgency, defined as an episode of acute severe hypertension without evidence of target-organ damage. We sought to evaluate the short-term risk of MACE after an emergency department (ED) visit for hypertensive urgency resulting in discharge to home. METHODS: We performed a case-crossover study using deidentified administrative claims data. Our case periods were 1-week intervals from 0 to 12 weeks before hospitalization for MACE. We compared ED visits for hypertensive urgency during these case periods versus equivalent control periods 1 year earlier. Hypertensive urgency and MACE components were all ascertained using previously validated International Classification of Diseases , Tenth Revision Clinical Modification codes. We used McNemar test for matched data to calculate risk ratios. RESULTS: Among 2 225 722 patients with MACE, 1 893 401 (85.1%) had a prior diagnosis of hypertension. There were 4644 (0.2%) patients who had at least 1 ED visit for hypertensive urgency during the 12 weeks preceding their MACE hospitalization. An ED visit for hypertensive urgency was significantly more common in the first week before MACE compared with the same chronological week 1 year earlier (risk ratio, 3.5 [95% CI, 2.9–4.2]). The association between hypertensive urgency and MACE decreased in magnitude with increasing temporal distance from MACE and was no longer significant by 11 weeks before MACE (risk ratio, 1.2 [95% CI, 0.99–1.6]). CONCLUSIONS: ED visits for hypertensive urgency were associated with a substantially increased short-term risk of subsequent MACE.


  • Cerebral Amyloid Angiopathy-Related Inflammation Presenting as Nontraumatic Subdural Hematoma

    by Samuel S. Bruce, Santosh B. Murthy, Neal S. Parikh, Andrew D. Schweitzer, Michelle Roytman, Benjamin Liechty, Babacar Cisse, Kyriakos A. Kirou, Babak B. Navi


  • Missed cerebrovascular events during prolonged sedation for COVID-19 pneumonia

    by Samuel S. Bruce, Joshua Kahan, Tashfin Huq, Alejandro Santillan, Babak B. Navi, Alexander E. Merkler, Neal S. Parikh, Saad Mir, Andrew D. Schweitzer, Alan Z. Segal


  • Open Access

    Risk of Ischemic Stroke in Patients with Covid-19 versus Patients with Influenza

    by Alexander E. Merkler, Neal S. Parikh, Saad Mir, Ajay Gupta, Hooman Kamel, Eaton Lin, Joshua Lantos, Edward J. Schenck, Parag Goyal, Samuel S. Bruce, et al.

    Importance: Case series without control groups suggest that Covid-19 may cause ischemic stroke, but whether Covid-19 is associated with a higher risk of ischemic stroke than would be expected from a viral respiratory infection is uncertain. Objective: To compare the rate of ischemic stroke between patients with Covid-19 and patients with influenza, a respiratory viral illness previously linked to stroke. Design: A retrospective cohort study. Setting: Two academic hospitals in New York City. Participants: We included adult patients with emergency department visits or hospitalizations with Covid-19 from March 4, 2020 through May 2, 2020. Our comparison cohort included adult patients with emergency department visits or hospitalizations with influenza A or B from January 1, 2016 through May 31, 2018 (calendar years spanning moderate and severe influenza seasons). Exposures: Covid-19 infection confirmed by evidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the nasopharynx by polymerase chain reaction, and laboratory-confirmed influenza A or B. Main Outcomes and Measures: A panel of neurologists adjudicated the primary outcome of acute ischemic stroke and its clinical characteristics, etiological mechanisms, and outcomes. We used logistic regression to compare the proportion of Covid-19 patients with ischemic stroke versus the proportion among patients with influenza. Results: Among 2,132 patients with emergency department visits or hospitalizations with Covid-19, 31 patients (1.5%; 95% confidence interval [CI], 1.0%-2.1%) had an acute ischemic stroke. The median age of patients with stroke was 69 years (interquartile range, 66-78) and 58% were men. Stroke was the reason for hospital presentation in 8 (26%) cases. For our comparison cohort, we identified 1,516 patients with influenza, of whom 0.2% (95% CI, 0.0-0.6%) had an acute ischemic stroke. After adjustment for age, sex, and race, the likelihood of stroke was significantly higher with Covid-19 than with influenza infection (odds ratio, 7.5; 95% CI, 2.3-24.9). Conclusions and Relevance: Approximately 1.5% of patients with emergency department visits or hospitalizations with Covid-19 experienced ischemic stroke, a rate 7.5-fold higher than in patients with influenza. Future studies should investigate the thrombotic mechanisms in Covid-19 in order to determine optimal strategies to prevent disabling complications like ischemic stroke.


  • Open Access

    Mobile Phone-Connected Wearable Motion Sensors to Assess Postoperative Mobilization

    by Geoff Appelboom, Blake E Taylor, Eliza Bruce, Clare C Bassile, Corinna Malakidis, Annie Yang, Brett Youngerman, Randy D'AMico, Sam Bruce, Olivier Bruyère, et al.

    Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.